THC Tenet Healthcare Corporation

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Tenet Healthcare Corp. - THC

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Tenet Healthcare Corp. (NYSE:THC) resulting from allegations that Tenet may have issued materially misleading business information to the investing public.

On October 3, 2016, Tenet disclosed that it would pay states and the federal government $514 million to settle allegations that its hospitals in Georgia and South Carolina paid kickbacks for obstetric referrals. Under the settlement, two Tenet subsidiaries will plead guilty to one count of conspiracy to violate federal kickback laws. On this news, shares of Tenet fell $0.91 per share or over 4% to close at $21.57 per share on October 3, 2016.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Tenet investors. If you purchased shares of Tenet on or before October 3, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-963.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
04/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tenet Healthcare Corporation

Tenet Healthcare Corp: 2 directors

Two Directors at Tenet Healthcare Corp sold 8,574 shares at between 173.000USD and 173.160USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Expecting a Test of All-Time Highs The market remains relentlessly strong, shrugging off the latest "bearish" headline regarding Moody's U.S. debt downgrade on Friday. This is exactly what we would expect to happen in a bull market, particularly during this "lockout rally," and helps confirm our bullish outlook. To recap, we have been short-term bullish since our 4/22/25 Compass -- when the SPX was testing 5100-5120 support -- but we upgraded our intermediate-term outlook to bullish as well, as...

Tenet Healthcare Corporation: Update to credit analysis following upgr...

Our credit view of this issuer reflects its considerable scale and its very good liquidity and favorable debt maturity profile, offset by its moderately high financial leverage.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch